Location History:
- Milpitas, CA (US) (2020)
- Los Altos, CA (US) (2019 - 2023)
Company Filing History:
Years Active: 2019-2025
Title: Innovations by Per John Sjolund in Diabetes Management
Introduction
Per John Sjolund is an accomplished inventor based in Los Altos, California. He has made significant contributions to the field of medical technology, particularly in diabetes management. With a total of 4 patents, his work focuses on improving the lives of individuals with diabetes through innovative solutions.
Latest Patents
One of Per John Sjolund's latest patents involves a sophisticated insulin delivery system. This system includes an insulin delivery device equipped with a user interface that features multiple user-selectable icons or buttons, each representing different meal characteristics. The device is designed to store user-specific dosage parameters in memory and is equipped with a processor that communicates with this memory. The processor is capable of receiving blood glucose data and determining initial meal characteristics based on user-specific dosage parameters. Additionally, it can update these meal characteristics based on the received blood glucose data, enhancing the overall management of diabetes.
Career Highlights
Per John Sjolund is currently associated with Bigfoot Biomedical, Inc., a company dedicated to advancing diabetes management technologies. His work at Bigfoot Biomedical has positioned him as a key player in the development of innovative medical devices that cater to the needs of diabetic patients.
Collaborations
Throughout his career, Per John Sjolund has collaborated with notable professionals in the field, including Lane Desborough and Bryan Mazlish. These collaborations have further enriched his contributions to medical technology and innovation.
Conclusion
Per John Sjolund's innovative work in diabetes management exemplifies the impact of technology on healthcare. His patents and contributions continue to pave the way for advancements in medical devices that improve patient outcomes.